Perverse Reverse Price Competition: Average Wholesale Prices and Medicaid Pharmaceutical Spending
NBER Working Paper No. 19367
---- Acknowledgements ----
We are grateful for helpful comments from three anonymous referees, the editor Joseph Doyle, Ernie Berndt, Rena Conti, Guy David, Mireille Jacobson, Andrew Mulcahy, David Powell, and seminar and conference participants at the American Society of Health Economists, Columbia University, RAND, University of California-Riverside, University of Oregon, and Wharton. We thank Brian Collopy and Samuel Hollin for excellent research assistance. Alpert gratefully acknowledges financial support from the RAND Bing Center for Health Economics and Duggan thanks the Dean's Research Fund at the Wharton School for financial support. All errors are our own. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.